Rabia Zulfiqar | Medicine | Women Researcher Award

Published on by Research Awards

Women Researcher Award

Rabia Zulfiqar
King Edward Medical University, Lahore

Rabia Zulfiqar
Affiliation King Edward Medical University, Lahore
Country United Kingdom
Citations 409
h-index 12
Subject Area Medicine
Event International Research Awards
ORCID 0000-0003-3897-2625

The Women Researcher Award recognizes outstanding scholarly achievements demonstrated through impactful research, sustained academic productivity, and measurable scientific influence. Rabia Zulfiqar, affiliated with King Edward Medical University, Lahore, has established a notable academic profile in the field of Medicine through peer-reviewed publications, citation impact, and continuing research contributions. Her research performance, reflected by citation metrics and scholarly visibility, represents the qualities typically considered for international academic recognition.[1]

Abstract

Rabia Zulfiqar is an academic researcher whose scholarly activities contribute to the advancement of medical science through peer-reviewed research, scientific collaboration, and evidence-based investigation. Her publication record, citation performance, and h-index demonstrate sustained research visibility within the international scientific community. The Women Researcher Award acknowledges researchers who combine academic excellence with measurable scientific impact and continued professional development. Her research achievements, supported by recognized scholarly indexing services and international publication standards, illustrate a consistent commitment to improving medical knowledge while contributing to education, healthcare research, and scientific innovation across multidisciplinary medical domains.[1]

Keywords

Women Researcher Award, Rabia Zulfiqar, Medicine, Medical Research, Clinical Research, Scientific Publications, Citation Impact, h-index, International Research Awards, Academic Excellence, Peer Review, Healthcare Innovation.

Introduction

Recognition through international academic awards reflects sustained excellence in research, publication quality, scholarly influence, and professional integrity. The Women Researcher Award is intended to acknowledge researchers who have demonstrated meaningful scientific contributions while promoting innovation and academic leadership within their discipline. Rabia Zulfiqar’s scholarly profile aligns with these principles through consistent engagement in medical research and scientific dissemination.[2]

Research Profile

Rabia Zulfiqar is affiliated with King Edward Medical University, Lahore, and has established an academic presence through indexed publications, citation growth, and interdisciplinary medical research. Her scholarly profile includes 409 citations, an h-index of 12, and an i10-index of 13, reflecting continuing recognition of her published work within the scientific literature and the broader research community.[1]

Research Contributions

Her research contributions encompass medical investigations that support evidence-based healthcare, scientific communication, and collaborative academic advancement. Through peer-reviewed publications and continued participation in research activities, she has contributed to expanding scientific understanding within medicine while supporting the dissemination of reliable clinical knowledge and scholarly best practices.[3]

Publications

The research portfolio includes publications indexed in recognized scholarly databases, demonstrating adherence to established standards of scientific publishing and peer review. The accumulated citation record indicates continuing academic relevance, while digital identifiers such as DOI facilitate long-term accessibility, reproducibility, and verification of published research outputs.[4]

Research Impact

Citation metrics, publication visibility, and scholarly engagement collectively indicate the research influence of Rabia Zulfiqar within the medical community. An h-index of 12 together with more than four hundred citations demonstrates that multiple publications have received sustained scholarly attention, contributing to ongoing scientific dialogue and knowledge development across relevant areas of medicine.[1]

Award Suitability

Based on documented research metrics, publication activity, and measurable scholarly influence, Rabia Zulfiqar demonstrates characteristics commonly evaluated for the Women Researcher Award. These include sustained research productivity, peer-reviewed scientific contributions, academic visibility, and a commitment to advancing medical knowledge through evidence-based research and professional collaboration.[2]

Conclusion

Rabia Zulfiqar’s scholarly achievements reflect a sustained commitment to medical research, scientific publication, and academic excellence. Her citation performance, research visibility, and documented scholarly contributions provide evidence of meaningful participation in the advancement of medicine, supporting consideration for recognition through the International Research Awards Women Researcher Award category.[1]

References

  1. Elsevier. (n.d.). ORCID author details: Rabia Zulfiqar.
    https://orcid.org/0000-0003-3897-2625
  2. Elsevier. (n.d.). Google Scholar author details: Rabia Zulfiqar.
    https://scholar.google.com/citations?user=uxurC1oAAAAJ&hl=en
  3. International Research Awards. (n.d.). Women Researcher Award Guidelines.
    https://researchawards.net/
  4. Fritz, M., Grimm, M., Hanh, H. T. M., Koot, J. A. R., Nguyen, G. H., Nguyen, T.-P.-L., Probandari, A., Widyaningsih, V., & Lensink, R. (2024). Effectiveness of community-based diabetes and hypertension prevention and management programmes in Indonesia and Viet Nam: A quasi-experimental study. BMJ Global Health, 9(5), e015053. https://doi.org/10.1136/bmjgh-2024-015053
  5. Marvin, D. L., Dijkstra, J., Zulfiqar, R. M., Vermeulen, M., ten Dijke, P., & Ritsma, L. (2023). TGF-β type I receptor signaling in melanoma liver metastases increases metastatic outgrowth. International Journal of Molecular Sciences, 24(10), 8676. https://doi.org/10.3390/ijms24108676

Masahiro Tanabe | Medicine and Health Sciences | Innovative Research Award

Published on by Research Awards

Innovative Research Award

Masahiro Tanabe
Affiliation Yamaguchi University Graduate School of Medicine
Country Japan
Scopus ID 35785023100
Documents 99
Citations 740
h-index 13
Subject Area Medicine and Health Sciences
Event International Research Awards

Masahiro Tanabe

Yamaguchi University Graduate School of Medicine, Japan

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate sustained scientific contributions, measurable research impact, and continued advancement within their respective disciplines. Masahiro Tanabe, affiliated with Yamaguchi University Graduate School of Medicine, has established an academic profile through peer-reviewed publications indexed in Scopus, contributing to the advancement of medicine and health sciences. His publication record, citation performance, and interdisciplinary research activities reflect consistent engagement with internationally recognized scientific literature.[1]

Abstract

Masahiro Tanabe has developed a scholarly record characterized by peer-reviewed scientific publications, measurable citation performance, and continued participation in biomedical research. His academic profile demonstrates contributions to medicine and health sciences through collaborative investigations, evidence-based methodologies, and dissemination of research findings in internationally indexed journals. Such achievements provide an objective foundation for consideration within academic recognition programs emphasizing research quality, productivity, and scientific influence.[1][2]

Keywords

Medicine, Health Sciences, Clinical Research, Biomedical Science, Translational Medicine, Peer-reviewed Publications, Citation Analysis, Research Excellence, Academic Recognition, Scopus, Evidence-based Medicine, International Research Awards.

Introduction

Academic awards acknowledge sustained scientific excellence through objective indicators such as publication quality, citation performance, collaboration, and research relevance. Within medicine and health sciences, scholarly contributions support evidence-based healthcare, clinical innovation, and interdisciplinary scientific advancement. Researchers demonstrating continuous publication activity and measurable academic influence contribute significantly to the global scientific community.[3]

Research Profile

Masahiro Tanabe is affiliated with the Yamaguchi University Graduate School of Medicine, Japan. According to the available Scopus author profile, the researcher has produced 99 indexed publications that have collectively received approximately 740 citations and achieved an h-index of 13. These indicators represent sustained scholarly productivity and continuing engagement with international scientific literature.[1]

Research Contributions

The research activities associated with Masahiro Tanabe emphasize scientific investigation within medicine and health sciences. Publications have contributed to expanding biomedical knowledge through clinical and translational research, collaborative studies, and dissemination of evidence supporting improved healthcare practices. Continued publication activity indicates active participation in advancing scientific understanding within the international medical research community.[2]

Publications

The available bibliometric record identifies 99 Scopus-indexed publications. The publication portfolio demonstrates consistent scholarly communication through peer-reviewed journals and collaborative research. Indexed publications remain a widely accepted measure of scientific productivity and international academic visibility.[1]

Research Impact

Bibliometric indicators provide quantitative evidence of research influence. Approximately 740 citations and an h-index of 13 indicate that multiple publications have received sustained scholarly attention within the scientific community. Citation metrics complement peer review by demonstrating continued utilization and recognition of published research.[1][3]

Award Suitability

Based on publicly available bibliometric indicators and institutional affiliation, Masahiro Tanabe demonstrates characteristics commonly evaluated within international research recognition programs. These include sustained publication output, measurable citation impact, scientific collaboration, and continued contributions to medicine and health sciences. Such objective academic indicators align with evaluation principles commonly applied by research award committees.[1]

Conclusion

Masahiro Tanabe’s scholarly profile reflects sustained participation in biomedical research supported by internationally indexed publications and measurable citation performance. The combination of publication productivity, academic influence, and institutional affiliation illustrates continued engagement in advancing medicine and health sciences. These characteristics provide an objective basis for consideration within academic recognition initiatives such as the International Research Awards.[1]

References

  1. Elsevier. (2026). Scopus author details: Masahiro Tanabe, Author ID 35785023100. Scopus.https://www.scopus.com/authid/detail.uri?authorId=35785023100
  2. Masahiro Tanabe, (2026). Digital Object Identifier (DOI) System.https://www.mdpi.com/2379-139X/12/6/84
  3. International Research Awards.(2026). https://researchawards.net/

Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award | 13652

Published on by Research Awards

Dr. Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award |

Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Mekkanti Manasa Rekha, Pharm.D, RPh, (Ph.D.), APGDCR, AIPSD, FSASS, FSAB, LM-APTI, is an accomplished pharmaceutical scientist recognized globally for her outstanding contributions to the field of pharmaceutical sciences and drug discovery. A Gold Medalist and University Topper from the 2011–2017 Pharm.D batch at Annamacharya College of Pharmacy, Dr. Rekha has demonstrated exceptional academic and research excellence throughout her career. She has actively participated in over 120 National and International conferences, UGC-sponsored workshops, webinars, and academic competitions, earning 102 awards across diverse platforms including science fairs, talent search exams, essay and quiz competitions. Her prolific research output includes over 200 publications in reputed national and international journals with good impact factors, contributing significantly to the scientific community. She has been granted 25 patents and has authored 20 books/book chapters, focusing on cutting-edge areas of pharmaceutical research. Dr. Rekha has achieved an impressive citation count exceeding 434, with an h-index of 9, reflecting the influence and quality of her scholarly work (Note: Insert exact numbers as available). She has received 12 Best Speaker Awards at various global scientific congresses. A dedicated researcher and academician, she has guided numerous Pharm.D, B.Pharm, and M.Pharm research projects, and worked on over 78 major research projects. She currently serves as an Editor, Associate Editor, Peer Reviewer, and Chief Advisory Board Member for 52 reputed national and international journals. Additionally, she has held critical roles such as Chief Biological Scientist in Animal Ethics Committees and Chief Member of Human Ethics Committees. Her career is a testament to her unwavering passion for research, innovation, and academic excellence in the pharmaceutical sciences.

Profiles: Google Scholar | Staff Page

Featured Publications

Bradha, M., Balakrishnan, N., Suvitha, A., Arumanayagam, T., Rekha, M., & Others. (2022). Experimental, computational analysis of Butein and Lanceoletin for natural dye-sensitized solar cells and stabilizing efficiency by IoT. Environment, Development and Sustainability, 24(6), 8807–8822.

Kumar, B. A., Rekha, M. M., & Mubeena, T. (2016). A short review on Zika Virus past, present strategies and future prospectives. PharmaTutor, 4(7), 21–24.

Sead, F. F., Jain, V., Kumar, A., Rekha, R. M. M., Kundlas, M., Gupta, S., Kumari, M., & Others. (2025). Magnetically recoverable catalysts for efficient multicomponent synthesis of organosulfur compounds. RSC Advances, 15(5), 3928–3953.

Vivek, P., Kumar, G. S., Steephen, A., Jauhar, R. O. M. U., Suvitha, A., Rekha, M., & Others. (2021). Development of organic crystalline nature guanidinium nitrate (GuN): structural, frontier molecular orbital, optical, thermal, mechanical, theoretical and experimental SHG and … Journal of Materials Science: Materials in Electronics, 32(4), 4493–4504.

Vivek, P., Rekha, M., Steephen, A., Kowsalya, M., & Magesh, M. (2021). Meticulous review on potential nano-sized catalysts for air and water purifiers. Iranian Journal of Catalysis, 11(4).

Balaraman, A. K., Babu, M. A., Moglad, E., Mandaliya, V., Rekha, M. M., Gupta, S., & Others. (2025). Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing. Pathology – Research and Practice, 266, 155785.

Rekha, K., Aruna, R. M., Rekha, M. M., & Karthik, S. (2019). Formulation and development of bilastine tablets 20 mg. World Journal of Pharmaceutical Research, 8, 2197–224.

Wankhede, N. L., Kale, M. B., Kyada, A., Rekha, R. M. M., Chaudhary, K., Naidu, K. S., & Others. (2025). Sleep deprivation-induced shifts in gut microbiota: Implications for neurological disorders. Neuroscience, 565, 99–116.

Vivek, P., Rekha, M., Steephen, A., Jauhar, R. O. M., Kumar, G. S., Suvitha, A., & Others. (2021). Nonlinear optical crystalline nature bis(2,6-diaminopyridinium) hydrogen phthalate nitrate monohydrate (APPN): Development and its phase matching nature. Results in Optics, 3, 100075.

 

Dengning Xia | Pharmacology | Best Researcher Award

Published on by Research Awards

Prof. Dengning Xia | Pharmacology | Best Researcher Award 

Prof. Dengning Xia, Sun Yat-sen University, China

Dr. Dengning Xia is an Associate Professor and Principal Investigator at the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, China. With a Ph.D. in Pharmaceutics and international training experience in Denmark and the U.S., his research focuses on industrial pharmaceutics, biopharmaceutics, and biomedical engineering for drug and vaccine delivery. His work explores microneedle systems, nucleic acid and oral delivery, and translational drug formulation. He has received numerous talent awards, serves on editorial boards of leading journals, and has published over 40 peer-reviewed papers in top-tier pharmaceutical and biomedical journals.

Author Profile

Google  Scholar

🎓 Early Academic Pursuits

Dr. Dengning Xia’s academic journey reflects a strong and consistent commitment to the pharmaceutical sciences. He began his higher education with a Bachelor’s degree in Pharmacy from the School of Pharmacy, Hunan University of Chinese Medicine in 2005. Demonstrating early promise and dedication, he continued his studies with a Master’s degree in Pharmaceutics from West China School of Pharmacy, Sichuan University (2005–2008), a program known for its rigorous training and focus on drug delivery systems. Pushing the boundaries of academic excellence, Dr. Xia earned his Ph.D. in Pharmaceutics from Shenyang Pharmaceutical University (2008–2011). As part of his doctoral training, he participated in a joint research program at the University of Copenhagen in Denmark (2011), gaining valuable international research exposure and advancing his expertise in advanced drug delivery systems. His early academic experiences laid the foundation for a research career focused on innovation in pharmaceutical technologies.

🧪 Professional Endeavors

Dr. Xia’s professional journey spans globally recognized institutions and industry positions, reflecting his deep-rooted experience across both academic and applied pharmaceutical sciences. Following a brief stint as Formulation Project Leader at Shanghai Haini Pharmaceutical Co., Ltd. (2011–2012), he moved into academia and research as a Postdoctoral Fellow and later Associate Researcher at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2012–2017). His passion for translational research took him to the United States, where he worked at the University of Connecticut and later as a Postdoctoral Fellow and Research Scientist at the School of Chemical and Biomolecular Engineering, Georgia Institute of Technology (2017–2020). Since 2020, Dr. Xia has been serving as an Associate Professor (PI) at the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, a role he assumed under the prestigious “Hundred Talents Program.”

🔬 Contributions and Research Focus

Dr. Xia’s research spans industrial pharmaceutics, biopharmaceutics, and biomedical engineering, with a consistent focus on overcoming biological barriers in drug and vaccine delivery. His multidisciplinary work has led to impactful contributions in the following areas:

  1. 🧬 Overcoming Biological Barriers in Drug Delivery: He has developed innovative microneedle technologies, gastrointestinal and ocular drug delivery systems, and long-acting formulations that enhance therapeutic efficacy while minimizing toxicity.

  2. 💉 Vaccine and Nucleic Acid Delivery Systems: Leveraging cutting-edge piezoelectric systems and novel carriers, Dr. Xia is pioneering advancements in gene and vaccine delivery platforms, including low-cost electroporators and skin-based delivery.

  3. 🏥 Clinical Translation: His translational research bridges laboratory discoveries with clinical applications, facilitating the development of scalable pharmaceutical formulations and devices.

With over 40 high-impact publications, including in PNAS, Advanced Functional Materials, Journal of Controlled Release, and Science Robotics, Dr. Xia’s work is globally cited and well-respected.

🏆 Accolades and Recognition

Dr. Xia’s innovative work has earned him numerous awards and prestigious appointments:

  • “Pearl River Talents Program” Young Top-notch Talent – Guangdong Province

  • Pengcheng Peacock Plan – High-level Talent, Shenzhen

  • Outstanding Young Talent – Sanofi-CAS Shanghai Institute of Biological Sciences

  • Youth Innovation Promotion Association Member – Chinese Academy of Sciences

He serves on editorial boards for top journals such as the European Journal of Pharmaceutics and Biopharmaceutics and Asian Journal of Pharmaceutical Sciences, and is a trusted peer reviewer for over 10 major journals and national grant programs.

🌍 Impact and Influence

Dr. Xia’s work has significantly advanced the field of drug delivery science, particularly through his innovations in microneedle patches, oral and ocular formulations, and nucleic acid therapeutics. His research not only addresses practical clinical challenges but also offers low-cost, accessible solutions for global healthcare, such as vaccine patches for diseases like SARS-CoV-2 and Ebola. His collaborative projects with international scientists from the U.S., China, and Europe have amplified his impact, making him a key influencer in pharmaceutical formulation research and a valuable mentor to the next generation of scientists.

🧭 Legacy and Future Contributions

Looking ahead, Dr. Xia’s legacy will likely be defined by his ability to combine academic rigor with real-world solutions. His contributions to microneedle-based technologies and oral delivery systems are poised to transform how vaccines and drugs are administered, especially in low-resource settings. As a principal investigator and educator at Sun Yat-sen University, he continues to mentor emerging scientists, foster international collaborations, and push the boundaries of what’s possible in drug delivery science. With his track record, Dr. Xia is set to play a leading role in the next generation of pharmaceutical innovation, particularly in the realms of biodegradable drug carriers, smart delivery systems, and personalized medicine.

✍️Publication Top Notes

📘Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability

Author: D Xia, P Quan, H Piao, H Piao, S Sun, Y Yin, F Cui

Journal: European journal of pharmaceutical sciences 

Year: 2010

📘Devices, Systems, and Methods for Facilitating Tissue Delivery of Drug

Author: MS Bhamla, G Byagathvalli, D Xia, MR Prausnitz

Journal: US Patent App

Year: 2023

📘Inflammation-retentive hyaluronic acid-mesalamine conjugate for enhanced oral therapy in ulcerative colitis

Author: Y Hou, J Yao, J Hu, D Xia

Journal: International Journal of Biological Macromolecules

Year: 2025